IPBF: who are we ?

site map  
interstitial cystitis &
bladder pain syndrome (IC/BPS)
Hunner lesion  
hypersensitive bladder  
other pelvic pain conditions  
overactive bladder syndrome  
associated disorders  
the urinary tract: how it works  
news & reviews  
literature: selected topics  
IPBF newsletters  
IPBF publications  
information in other languages  
glossary of terms: A-Z  
information for professionals  
books, videos, CDs  
how to start and run a support group  
global IC/BPS support groups, contact persons and related organizations  
donations & sponsoring  
useful links  
disclaimer & copyright  


selected literature on fibromyalgia    
click on the title to jump to the abstract if available
  • American Journal of Medicine December 2009 - Supplement on Fibromyalgia

Fibromyalgia is a controversial disease. Clauw DJ. Am J Med 2009;122(12 Suppl):S1-2

Fibromyalgia: an overview. Clauw DJ. Am J Med 2009;122(12 Suppl):S3-S13

Diagnosis and differential diagnosis of fibromyalgia. Goldenberg DL. Am J Med 2009;122(12 Suppl):S14-21

Pathophysiology of fibromyalgia. Bradley LA. Am J Med 2009;122(12 Suppl):S22-30

Strategies for managing fibromyalgia. Arnold LM. Am J Med 2009;122(12 Suppl):S31-43

Further strategies for treating fibromyalgia: the role of serotonin and norepinephrine reuptake inhibitors. Mease PJ. Am J Med 2009;122(12 Suppl):S44-55

  • A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome.
    Uçeyler N, Häuser W, Sommer C. Arthritis Rheum 2008;59:1279-98
    • in this systematic review it is concluded that amitriptyline (25-50 mg/day) reduced pain, fatigue, and depressiveness in patients with fibromyalgia and improved sleep and quality of life

    • most SSRIs and the SNRIs duloxetine and milnacipran are probably also effective
    • the authors recommend short-term treatment of patients with fibromyalgia using amitriptyline or another of the antidepressants that were effective in randomized-controlled trials but warn that data on long-term efficacy are lacking
  • The Fibromyalgia Bladder Index.
    Brand K, Littlejohn G, Kristjanson L, et al. Clin Rheumatol 2007;26:2097-103
    • the aim of this study was to determine whether the Interstitial Cystitis Symptom and Problem Index (ICSI/ICPI), is a valid, reliable, and clinically relevant instrument to assess the sensory urinary symptoms in women with fibromyalgia syndrome (FM)
    • factor analysis displayed two separate components of symptom and problem combinations as distinct from the original ICSI/ICPI developed for the interstitial cystitis population
    • the eight items of the index configured differently and formed two subscales of a newly developed Fibromyalgia Bladder Index
    • the two subscales of this index include the Bladder Urgency and Pain Subscale and the Bladder Frequency and Nocturia Subscale.
  • Review of the Chinese medical approach to the management of fibromyalgia.
    Zheng L, Faber K. Curr Pain Headache Rep 2005 Oct;9(5):307-12
    • Traditional Chinese Medicine (TCM) has a long history of efficacy in treating chronic illness. This article briefly introduces the TCM model of human physiology and TCM diagnostics and describes the TCM pathophysiology and treatment models for fibromyalgia.
  • Antidepressants and cognitive-behavioral therapy for symptom syndromes.
    Jackson JL, O'malley PG, Kroenke K. CNS Spectr 2006;11:212-22
    • this article reviews the randomized controlled trial data for the use of antidepressant and cognitive-behavior therapy for 11 somatic syndromes: irritable bowel syndrome, chronic back pain, headache, fibromyalgia, chronic fatigue syndrome, tinnitus, menopausal symptoms, chronic facial pain, noncardiac chest pain, interstitial cystitis, and chronic pelvic pain
  • Fibromyalgia Syndrome
    Canadian Clinical Working Case Definition, Diagnostic and Treatment Protocols - a consensus document
updated 12.01.2010 17:20 © 2006-2018 International Painful Bladder Foundation (IPBF). All rights reserved.